Find Resources
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
This paper analyzes the policy components that contribute to the programmatic success of flu and Tdap pregnancy vaccine programs in three high-income countries, including the United States. Key pillars to increased vaccination coverage include Health Authority accountability, facilitated patient access to vaccination, healthcare professional accountability and engagement, awareness of the burden and severity of diseases, and finally, belief in the benefits of pregnancy vaccination. In the US, given the higher diversity of stakeholders, a multi-stakeholder approach with calls to action from the CDC and endorsement from other scientific societies were key to uptake of vaccinations in pregnancy. It is recommended that maternal task forces reinforce these messages, disseminate toolkits, and that partners address barriers that stand in the way of vaccination, including ensuring that vaccination clinics are convenient for pregnant woman. Successful programs do not require implementation of all components; instead, public health experts should use these as components as guiding tools that can be refined depending on the specificities of the healthcare system in place.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study, Summary Report/Recommendations
The guidance outlined in this report provides a roadmap for the ethical inclusion of pregnant women’s experiences in in the development and deployment of vaccines against emerging viruses. Recommendations include bolstering health information surveillance systems, stakeholder engagement with health care, women, families and communities, and changing the narrative about pregnancy and clinical research efforts. Recommendations require commitment of financial resources, addressing inequities in public health and whenever possible, the inclusion of perspectives of pregnant women. Lastly, the authors recommend that “When there is a limited supply of vaccine against a pathogenic threat that disproportionately affects pregnant women, their offspring, or both, or when only one vaccine among several is appropriate for use in pregnancy, then pregnant women should be among the priority groups to be offered the vaccine.” This prioritization process is key to addressing inequities and are guidance for future pandemic response efforts.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Peer Review Study
Maternity healthcare professionals (MHCPs) play an important role in promoting vaccines and influencing the perspectives of pregnant women. This systematic review outlines the views and experiences of these key workforce members involved in the provision of the maternal influenza vaccine worldwide. In order to promote vaccine uptake, results indicate that it is important to educate MHCPs, ensure there is sufficient time for discussions, and implement electronic vaccination prompts. These, in addition to national policies and guidelines, helped increase the confidence of these professionals in recommending vaccination.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study
The guidance outlined in this report provides a roadmap for the ethical inclusion of pregnant women’s experiences in the development and deployment of vaccines against emerging viruses. Recommendations include (1) bolstering health information surveillance systems, (2) stakeholder engagement with health care, women, families and communities, and (3) changing the narrative about pregnancy and clinical research efforts. Recommendations require commitment of financial resources, addressing inequities in public health, and whenever possible, the inclusion of perspectives of pregnant women. Lastly, the authors recommend that “When there is a limited supply of vaccine against a pathogenic threat that disproportionately affects pregnant women, their offspring, or both, or when only one vaccine among several is appropriate for use in pregnancy, then pregnant women should be among the priority groups to be offered the vaccine.” This prioritization process is key to addressing inequities and are guidance for future pandemic response efforts.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Summary Report/Recommendations
In this report, the National Vaccine Advisory Committee (NVAC) discusses maternal immunizations best practices, as well as gaps to implementation recommendations. One recommendation includes focusing efforts to improve financing for immunization services during pregnancy and the postpartum period. Public health and health care partners can support efforts promoting new payment and delivery models, patient-centered medical homes, and accountable care organizations. NVAC also recommends partnering with professional organizations and other maternal immunization stakeholders to develop toolkits and guidance for improving processes.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This report details the immense toll the COVID-19 pandemic has taken, and continues to take, on Black communities. The report’s authors – physicians and public health and policy experts – note massive disparities experienced by Black Americans. The worse outcomes, are a predictable result of structural and social realities. The predicates that caused these disparities have long been present. These are cycles we have to break. The report highlights areas for immediate focus and attention, and presents a set of expert-generated recommendations for action.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This report highlights the efficacy of COVID-19 mRNA vaccines (2-dose series) for pregnant mothers and their infants. In the aftermath of the Delta and Omicron waves, infants born to unvaccinated mothers were more likely to be among those hospitalized for COVID-19.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Summary Report/Recommendations
This report from RAND Corporation presents the results of a nationally-representative survey of Black Americans, coupled with follow-up data collected through interviews with survey participants who expressed vaccine hesitancy. The report identifies factors contributing to mistrust and provides recommendations to improve health messaging and communication to address vaccine hesitancy in Black communities. The practice strategy this resource is focused on is reducing vaccine hesitancy.
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Peer Review Study
The resource presents 7 recommendations to mitigate COVID-19 health disparities among African Americans in the areas of data collection, COVID-19 exposure and testing, health systems collaboration, human capital repurposing, and resource allocation. The authors based the recommendations on the existing public health literature and and on an analysis of relevant bioethical principles. The authors also provide information on the efforts of Chicago, Illinois’ mayoral Racial Equity Rapid Response Team to reduce these disparities in a major urban US setting.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This commentary article summarizes community-academic partnerships and how they can be used to address vaccine hesitancy among Black and Hispanic/Latinx communities. The authors conclude that pro-vaccine interventions need to: (1) be empathetic to the fears of participants, (2) make a personal connection (e.g., appropriate self-disclosure), (3) deliver accurate information in a non-confrontational manner, and (4) avoid belaboring historical maltreatment and unsupported conspiracies. Moreover, healthcare institutions need to collaborate with community stakeholders to increase access to vulnerable populations and rebuild trust prior to offering interventions.